<?xml version="1.0" encoding="UTF-8"?>

<?xml-stylesheet type="text/xsl" href="/static/oaitohtml.xsl"?>

<!--
<?xml-stylesheet type="text/xsl" href="/oaitohtml.xsl"?>
-->

<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <responseDate>2026-10-12T04:54:50Z</responseDate>
    <request verb="GetRecord" metadataPrefix="oai_dc" identifier="10.57760/sciencedb.nprd.00282" >https://www.scidb.cn/oai</request>
<GetRecord>
    <record>
    <header >
    <identifier>10.57760/sciencedb.nprd.00282</identifier>
    <datestamp>2026-07-24T10:38:33Z</datestamp>
</header>
    <metadata>
        
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:date>2026-07-24</dc:date>
  <dc:title>Investigating the mechanism of ferulic acid and cisplatin-containing serum inhibiting invasion of triple-negative breast cancer based on CBX2 knockdown and EGFR/PI3K pathway_raw data</dc:title>
  <dc:identifier>doi:10.57760/sciencedb.nprd.00282</dc:identifier>
  <dc:language>en</dc:language>
  <dc:description>This study aims to investigate the effects of ferulic acid (FA) and cis-diaminodichloroplatinum (CDDP) containing serum (FCCS) on the invasion and migration of breast cancer cells by regulating the epidermal growth factor receptor (EGFR)/phosphatidylinositol 3-kinase (PI3K) pathway. Different groups of FCCS were prepared, and both CBX2&amp;nbsp;knockdown and normal MDA-MB-453 and 4T1 cells were divided into the following groups: control (Con), Con＋CBX2 of short hairpin RNA (Con+shCBX2), FCCS, FCCS+shCBX2, FCCS+shCBX2+LY294002(PI3K&amp;nbsp;inhibitor), and CDDP. After 48 hours of intervention, cell proliferation inhibition was assessed using the CCK-8 assay; apoptosis was detected by flow cytometry; cell migration and invasion were evaluated using transwell chambers; ELISA was used to measure the expression of E-cadherin, N-cadherin, and VE-cadherin in cell culture supernatants; Western blot was performed to analyze the expression of phosphorylated EGFR (p-EGFR), phosphorylated PI3K (p-PI3K), E-cadherin, and N-cadherin in cells. Compared with Con group, Con+shCBX2, FCCS, FCCS+shCBX2, and FCCS+shCBX2+LY294002 groups significantly inhibited the proliferation of 4T1 and MDA-MB-453 cells, with the strongest inhibition observed in the FCCS+shCBX2+LY294002 group (all P&amp;nbsp;&amp;lt; 0.05). Annexin V-FITC/PI staining, ELISA, and Western blot results showed that, compared with Con group, FCCS, FCCS+shCBX2, and FCCS+shCBX2+LY294002 groups exhibited significantly increased apoptosis rates (P&amp;nbsp;&amp;lt; 0.05). The EGFR/PI3K signaling pathway was involved in FCCS-mediated suppression of proliferation, apoptosis, and invasion in 4T1 and MDA-MB-453 cells.</dc:description>
  <dc:subject>breast cancer; PI3K; EGFR</dc:subject>
  <dc:creator>xing yu shu</dc:creator>
  <dc:rights>RESTRICTED</dc:rights>
  <dc:type>dataset</dc:type>
  <dc:publisher>Science Data Bank</dc:publisher>
</oai_dc:dc>

    </metadata>
</record>
</GetRecord>
</OAI-PMH>